1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
2Research and Clinical Center for Physical Chemical Medicine, Moscow, Russia.
Nucleic Acid Ther. 2019 Aug;29(4):208-217. doi: 10.1089/nat.2018.0757. Epub 2019 Mar 13.
Thrombin-binding aptamer HD1 is a DNA-based thrombin inhibitor that features an antiparallel G-quadruplex (GQ) structure. We recently reported a single-nucleotide G8 to 5-nitroindole (NI) modification of HD1 (N8) that notably improves the anticoagulant properties and binding affinity of the aptamer. Based on molecular modeling and binding studies, it was originally proposed that N8 may acquire the ability to bind thrombin by a modified central loop. To verify this possibility, in this study, we report new variations of the N8 aptamer with intact or damaged TT loops. Anomeric -thymidine was used as a "damaging" residue to disable the primary recognition site of N8. Biophysical characterization of modified aptamers supports the formation of HD1-like antiparallel GQs with varying stability by all studied variants. Binding experiments showed that N8 variants with impaired TT loops lost the ability to bind thrombin, suggesting the primary role of thymines in TT loops for the thrombin-N8 interaction. Aptamer N8α(7/9) bearing NI at position 8 and damaged thymidines 7 and 9 retained thrombin affinity, which was intermediate between N8 and HD1. Fluorescence polarization studies suggest 1:1 stoichiometry for thrombin complexes with either HD1, N8, or N8α(7/9). Further molecular dynamics (MD) study of complexes formed by these three aptamers with thrombin disproves the idea of direct interaction between central loop residues and the protein. Based on MD results, the origin of the NI tuning effect is associated with its ability to promote the formation of compact and rigid structures through hydrophobic interactions with the GQ core and loop thymines.
凝血酶结合适体 HD1 是一种基于 DNA 的凝血酶抑制剂,具有反平行 G-四链体(GQ)结构。我们最近报道了 HD1 的单个核苷酸 G8 到 5-硝基吲哚(NI)修饰(N8),这显著改善了适体的抗凝性质和结合亲和力。基于分子建模和结合研究,最初提出 N8 可能通过修饰的中央环获得与凝血酶结合的能力。为了验证这种可能性,在这项研究中,我们报告了具有完整或受损 TT 环的 N8 适体的新变体。α-胸腺嘧啶核苷被用作“破坏”残基,以使 N8 的主要识别位点失活。修饰适体的生物物理特性支持通过所有研究的变体形成具有不同稳定性的 HD1 样反平行 GQ。结合实验表明,TT 环受损的 N8 变体失去了与凝血酶结合的能力,这表明 TT 环中的胸腺嘧啶在凝血酶-N8 相互作用中起主要作用。在位置 8 带有 NI 且 7 和 9 位胸腺嘧啶受损的 N8α(7/9) 适体保留了与凝血酶的亲和力,介于 N8 和 HD1 之间。荧光偏振研究表明,与 HD1、N8 或 N8α(7/9) 形成的凝血酶复合物均为 1:1 计量比。对这三种适体与凝血酶形成的复合物进行进一步的分子动力学(MD)研究,否定了中央环残基与蛋白质之间直接相互作用的想法。基于 MD 结果,NI 调谐效应的起源与它通过与 GQ 核心和环胸腺嘧啶的疏水相互作用促进紧凑和刚性结构形成的能力有关。